Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MAST3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | FBLN7 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | RP1-27O5.3 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
mRNA | GSE1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
mRNA | TCF20 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
mRNA | EP400 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
mRNA | FERMT3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
mRNA | ZNF835 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
mRNA | SPSB3 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | GPR150 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |